FDA Clears Glaxo's Cervarix Vaccine - WSJ.com
Links shared publicly online about this topic.
- 1,672total visits
FDA Clears Glaxo's Cervarix Vaccine - WSJ.com
View full resource at online.wsj.com
Tags: Cervical Cancer, Cervical Cancer Prevention, Women's Health, FDA, Vaccine, HPV Vaccine, Cervarix, GlaxoSmithKline
Most Recently Shared on October 16, 2009 at 9:09 pm By:
FDA Clears Glaxo's Cervarix Vaccine http://bit.ly/oNPcN
FDA clears return of Rotarix vaccine - Kids and parenting- msnbc.com
msnbc.msn.com — “The Food and Drug Administration has cleared the use of GlaxoSmithKline PLC's Rotarix vaccine, which is designed to protect babies against a leading cause of diarrhea.” View full resource at msnbc.msn.com
Most Recently Shared on May 17, 2010 at 5:30 am By:
msnbc.com - Health Health News
FDA clears return of Rotarix vaccine http://bit.ly/9WVKeN
FDA clears Cervarix for 10- to 25-year-old females - Related Stories - AAP SmartBrief
smartbrief.com — “GlaxoSmithKline has won FDA approval for the use of human papillomavirus vaccine Cervarix in girls ages 10 to 25. The decision is based on clinical trials that demonstrated that Cervarix was 93% effective in protecting patients in the age group from cervical precancers associated with HPV 16 or HPV” View full resource at smartbrief.com
Most Recently Shared on October 20, 2009 at 3:32 am By:
Clara Song Pediatrician, Physician, and Doctor
FDA clears Cervarix for 10- to 25-year-old females http://sbne.ws/r/362P
FDA approves Cevarix for HPV and cervical cancer prevention - WEGO Health
community.wegohealth.com — “Time to watch your TV for more HPV (Genital human papillomavirus) commercials, Gardasil now has competition! As of this Friday, GlaxoSmithKline's Cevarix vaccination has been approved by the US Food & Drug Administration according to the Associated Press. Cervarix, like Gardasil, will inhibit strains 16 and 18 of HPV - two strains which cause 75% of cervical cancers. Although there are more than 100 identified strains of the human papillomavirus, only about 15 are known to cause cervical can” View full resource at community.wegohealth.com
Most Recently Shared on October 17, 2009 at 2:08 pm By:
Our Aloe Business Health Business
FDA approves Cevarix for HPV and cervical cancer prevention http://bit.ly/3IJsIO
FDA approves Cervarix, GlaxoSmithKline's cervical cancer vaccine
drugs.com — “Cervarix (Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant) is used for prevention of cervical cancer. Includes Cervarix side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 16, 2009 at 10:45 pm By:
FDA approves Cervarix, GlaxoSmithKline's cervical cancer vaccine - http://bit.ly/2Y6rH0
Cervarix approved for prevention of HPV-associated cervical cancer - MPR
empr.com — “The FDA has approved Cervarix (human papillomavirus bivalent [types 16 and 18] vaccine, recombinant, from GlaxoSmithKline) for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic human papillomavirus (HPV) types 16 and 18 for use in girls and women 10"25 years of age.” View full resource at empr.com
Most Recently Shared on October 16, 2009 at 8:55 pm By:
MPR News: Cervarix approved for prevention of HPV-associated cervical cancer: The FDA has approved Cerv.. http://bit.ly/WF8uF
FDA approves Glaxo's cervical cancer vaccine - Health- msnbc.com
msnbc.msn.com — “British drugmaker GlaxoSmithKline said Friday U.S. regulators approved its vaccine Cervarix to prevent the leading cause of cervical cancer in women.” View full resource at msnbc.msn.com
Most Recently Shared on October 16, 2009 at 7:37 pm By:
msnbc.com - Health Health News
FDA approves Glaxo's cervical cancer vaccine http://bit.ly/JC3ns
FDA Approves Cervarix, GlaxoSmithKline's Cervical Cancer Vaccine | Reuters
reuters.com — “PHILADELPHIA, Oct. 16 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved CERVARIX [Human papillomavirus bivalent (types” View full resource at reuters.com
Most Recently Shared on October 16, 2009 at 4:16 pm By:
Skin & Allergy News Health News
RT @Apfeiffer: RT @cancercures: FDA Approves Cervarix, GlaxoSmithKline's Cervical Cancer Vaccine http://bit.ly/3PBG9D
FDA delays decision on Cervarix; GSK recalls vaccine in U.K. - Related Stories - AAP SmartBrief
smartbrief.com — “The FDA delayed again its decision to approve cervical cancer vaccine Cervarix to further review GlaxoSmithKline's application. The agency's announcement came the same day GSK recalled a batch of Cervarix in the U.K. because a 14-year-old girl died after getting vaccinated. <a href='/servlet/aaRedir” View full resource at smartbrief.com
Most Recently Shared on October 1, 2009 at 1:49 am By:
Clara Song Pediatrician, Physician, and Doctor
FDA delays decision on Cervarix; GSK recalls vaccine in U.K. http://sbne.ws/r/2UZl
WRAPUP1-Glaxo's Cervarix vaccine faces delays, concerns | Reuters
reuters.com — “* FDA needs more time to weigh product * No indication delay is linked to UK death * Vaccine batch recalled following teenager's death * Cervarix gets support in Japan By Susan Heavey WASHINGTON,” View full resource at reuters.com
Most Recently Shared on September 29, 2009 at 7:55 pm By:
14 yr old dies shortly after getting Glaxo's Cervarix (cervical cancer) vaccine in Britain, U.S. delays vaccine approval http://ow.ly/rI0v
FDA approves second cervical cancer vaccine, Cervarix, for preventing HPV in women
nydailynews.com — “Federal health officials said Wednesday a long-delayed vaccine from GlaxoSmithKline successfully blocks the leading virus that causes cervical cancer in women.” View full resource at nydailynews.com
Most Recently Shared on September 10, 2009 at 3:34 pm By:
FDA backs new HPV vaccine, Cervarix: Federal health officials said Wednesday a long-delayed vaccine from GlaxoSm.. http://bit.ly/30QPTi
Merck and Glaxo Vie for HPV Billions - NYTimes.com
nytimes.com — “Merck and GlaxoSmithKline, with the support of federal panels, plan to expand use of their treatments against the human papillomavirus.” View full resource at nytimes.com
Most Recently Shared on September 10, 2009 at 1:56 pm By:
J Nat'l Cancer Inst Oncology and Medical Journal
HPV Vaccines: FDA advisory panel OKs Cervarix to protect women against cervical cancer & Gardasil for boys—NY Times http://bit.ly/di3Jt
FDA documents support efficacy of GSK's Cervarix - Related Stories - AAP SmartBrief
smartbrief.com — “The FDA said in online documents that GlaxoSmithKline's vaccine Cervarix was effective against the two most dangerous strains of human papillomavirus based on a study involving more than 18,000 women. An FDA panel is set this week to evaluate the use of Cervarix in girls and women ages 10 to 25. <a” View full resource at smartbrief.com
Most Recently Shared on September 10, 2009 at 3:18 am By:
Clara Song Pediatrician, Physician, and Doctor
FDA documents support efficacy of GSK's Cervarix http://sbne.ws/r/2JQd
FDA panel backs Glaxo's cervical vaccine for women
physorg.com — “(AP) -- Drugmaker Merck likely will face U.S. competition for its vaccine Gardasil, after federal experts recommended rival GlaxoSmithKline's Cervarix also be approved to prevent the virus that causes most cervical cancers.” View full resource at physorg.com
Most Recently Shared on September 10, 2009 at 12:19 am By:
FDA panel backs Glaxo's cervical vaccine for women http://bit.ly/1Zasoh
FDA panel backs Glaxo cervical cancer vaccine | Reuters
reuters.com — “GAITHERSBURG, Maryland (Reuters) - GlaxoSmithKline PLC's proposed cervical cancer vaccine is safe and effective for girls and young women ages 10 to 25, a U.S. advisory panel said on Wednesday. The endorsement” View full resource at reuters.com
Most Recently Shared on September 9, 2009 at 9:05 pm By:
Big news for Glaxo: ODAC backs approval of Cervarix for females aged 10 to 25. http://tiny.cc/mopeE
FDA Advisory Committee makes favorable recommendation for Cervarix, GlaxoSmithKline’s candidate cervical cancer vaccine
gsk.com — “GSK announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that clinical data support both the efficacy and safety of CERVARIX, the company’s candidate cervical cancer vaccine (12-1 and 11-1, respectively).” View full resource at gsk.com
Most Recently Shared on September 9, 2009 at 8:45 pm By:
eyeonfda Pharma and Health Lawyer
GSK - FDA AdComm makes favorable reco for Cervarix, GSK’s candidate cervical cancer vaccine http://bit.ly/GluBk
Advertisement
